BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 6 February 1997.
The conference, which took place in late January in Washington, D.C. is one of the most important gatherings in HIV/AIDS treatment information.
Data presented at the annual event suggests recent advances can possibly make HIV a chronic manageable illness. New medications including a second generation of protease inhibitors, and new classes of reverse trancriptase inhibitors used in combination have demonstrated the ability to lower the amount of virus in a person's blood, viral load, and increase T cells.
Improvements in treatments have also shown a reduction in the number of opportunistic infections in people with HIV.
Reviewing the conference findings will be:
-- Paul Volberding, M.D., Director, Center for AIDS Research at San Francisco General Hospital.
-- Marcus A. Conant, M.D., Medical Director, Conant Medical Group
-- Martin Delaney, Founding Director, Project Inform
-- Ronald Baker, Ph.D., Director, Treatment Education and Advocacy, San Francisco AIDS Foundation
The review takes place at the Hotel Nikko, 222 Mason Street at O'Farrell Street, Nikko Ballroom, Third Floor, Monday, Feb. 10, 6:30 p.m. to 7:30 p.m. A press conference is scheduled for 5:30 p.m. Admission is free.
This event is wheelchair accessible and translation will be provided for the hearing impaired.
The Marcus A. Conant Foundation is dedicated to helping the HIV community lead healthier lives through education and patient advocacy.
For more information or copies of the backgrounder, contact Scott Dowie or BJ Cavnor at 415/643-1822.
--30--jr/sf*
CONTACT: Marcus A. Conant Foundation Scott Dowie or BJ Cavnor, 415/643-1822 sdowie@aol.com or bjcavnor@aol.com
REPEATS: New York 212-752-9600 or 800-221-2462; Boston 617-236-4266 or 800-225-2030; SF 415-986-4422 or 800-227-0845; LA 310-820-9473 Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: http://www.businesswire.com
Copyright (c) 1997/BUSINESS WIRE. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854.
970206
BW970205
Copyright © 1997 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .